REVELATION BIOSCIENCES INC (REVB)

US76135L5075 - Common Stock

2.06  -0.14 (-6.36%)

After market: 2.01 -0.05 (-2.43%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
8.66M10.86M11.95M2.53M3.64K
Research and Development
4.15M5.38M6.91M1.71MN/A
Selling, General, and Administrative Expenses
4.51M5.49M5.04M820.00K3.64K
Operating Income
-8.66M-10.86M-11.95M-2.53M-3.64K
Interest Income/Expense
N/AN/A-52.00K9.08KN/A
Other Income/Expense
8.54M30.00K-40.00K0.00N/A
Income Before Taxes
-120.25K-10.83M-11.99M-2.53M-3.64K
Income Tax
N/AN/A0.00N/AN/A
Net Income
-120.25K-10.83M-11.99M-2.53M-3.64K
EBITDA
-8.63M-10.83M-11.93MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-0.53-20.05-17.89-3.76-0.00
Non GAAP EPS
55.27-75.85N/AN/AN/A
 
Statistics

All data in USD

Charts